Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2019, Vol. 39 Issue (12): 103-109    DOI: 10.13523/j.cb.20191213
    
Bio-tech Startup Incubation Best Practice in the United States
HU Yuan-lei1,YAO Wei-hao2,*(),PU Run3,*(),ZHANG Hong-xiang4,5
1 School of Life Sciences,Peking University, Beijing 100871,China
2 Office of Science and Technology Development, Institute of Industrial Technology Research, Peking University,Beijing 100871,China
3 China National Center for Biotechnology Development, Beijing 100039,China
4 Chinese Science Library, Chinese Academy of Science, Beijing 100190,China
5 Chinese Society of Biotechnology, Beijing 100101,China
Download: HTML   PDF(463KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Biotechnology and biopharmaceutical industries are the strategic sectors favored by major economies of the world in the 21 st century. Globally, these two sectors have gradually moved into the phase of large scale commercialization industrialization, and are expected to enter a stage of accelerated growth by 2020. They are expected to gradually become a key driver of world’s economy growth. China government has enacted a series of incentive measures and policies to foster a conducive ecosystem in order to accelerate the innovation and growth of the biotechnology and biopharmaceutical industries. With the call for innovation by central government, various provinces and cities of China have built series of biotechnology science parks and incubators to promote the incubation and growth of biotechnology startup companies, in an attempt to move up along the value chain. This paper provides an introduction to the establishment, operation and incubation practice of various successful biotechnology incubators in the United States, it also looks into the collaboration model between these incubators and external parties, from an ecosystem building perspective. Six guidelines were summarized for the successful operation of incubators and three suggestions were given aimed at serving as a reference for those who plan to build or operate a biotechnology / biopharmaceutical incubator.



Key wordsInnovation and startup eco-system      Biotechnology incubator      Biopharmacy     
Received: 20 May 2019      Published: 15 January 2020
ZTFLH:  Q819  
Corresponding Authors: Wei-hao YAO,Run PU     E-mail: whyao@pku.edu.cn;purun@cncbd.org.cn
Cite this article:

HU Yuan-lei,YAO Wei-hao,PU Run,ZHANG Hong-xiang. Bio-tech Startup Incubation Best Practice in the United States. China Biotechnology, 2019, 39(12): 103-109.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20191213     OR     https://manu60.magtech.com.cn/biotech/Y2019/V39/I12/103

孵化器 孵化器资金
来源
孵化对象 运营方式 导师系统 提供实验室 接受辅导企业
团队是否需要
入驻加速器
辅导时间
(length of
stay)
孵化器股权
比例
LabCentral 来自州政府和大学的启动资金和运营资金、制药公司(赞助的资金和设备) 主要来自哈佛、MIT初创企业和成长企业,对外开放 企业运营,自有品牌 多元化导师 共享实验室 要求 18个月
Indiebio 创投基金管理公司(SOS Venture) 全球初创企业 企业运营,品牌宣传 多元化导师,专业导师强大 共享实验室 要求 4个月 投资25万美元获得12%股份
YCombinator 创投基金、孵化器创始人自由资金 全球初创企业,分硬件、生技、教育和互联网等类别 企业运营,形成品牌 商业化导师 只需要创始人部分时间 3个月 加速器投资15万美元换取7%股权
Table 1 Incubator conditions
[1]   张东 . 科技企业孵化器运营中的常见问题及解决建议. 品牌研究, 2018, ( S2):143-146.
[1]   Zhang D . Common problems and solutions in the operation of science and technology business incubator. Jounal of Brand Research, 2018(S2):143-146.
[2]   Lewis D, Harper -Anderson E, Molnar L . Incubating success incubation best practices that lead to successful new ventures. 2011: 13-14.DOI: 10.13140/RG.2.1.2732.6881.
doi: 10.13140/RG.2.1.2732.6881
[3]   李争粉 . 专业孵化器成为产业集聚升级新引擎.[2016-02-01].
[3]   Li Z F . Professional incubator becomes a new engine of industrial agglomeration and upgrading.[2016-02-01].
[4]   付红波 . 美国生物科技及产业发展概况. 中国生物工程杂志, 2010,30(4):135-138.
[4]   Fu H B . Overview of biotechnology and industry development in the United States. China Biotechnology, 2010,30(4):135-138.
[5]   翁媛媛, 饶文军 . 生物技术产业集群发展机理研究——以美国波士顿地区为例. 科技进步与对策, 2010,27(6):54-59.
[5]   Weng Y Y, Rao W J . Study on the biotechnology industry cluster development mechanism,taking Boston area as an example. Science & Technology Progress and Policy, 2010,27(6):54-59.
[6]   郑娟, 孔钢城 . 利益相关者视角下的MIT创业生态系统研究.高等工程教育研究. 2017, ( 5):163-168.
[6]   Zheng J, Kong G H . Research on MIT entrepreneurship ecosystem from stakeholder perspective. Research in Higher Education of Engineering, 2017(5):163-168.
[7]   Roberts E B, Murray F, Kim J D. Entrepreneurship and innovation at MIT:continuing global growth and impact-an updated report.[ 2019-03-10]. .
[8]   黄亚生 . MIT创新课:麻省理工模式对中国创新创业的启迪.北京:中信出版集团股份有限公司. 2015.
[8]   Huang Y S. MIT innovation course:The enlightenment of mit model on innovation and entrepreneurship in China. Beijing:CITIC Press Group. 2015.
[9]   濮润, 郭伟, 李萍萍 , 等. 我国生物医药产业聚集效应分析及发展建议. 中国医药生物技术, 2018,13(6):564-565.
[9]   Pu R, Guo W, Li P P , et al. Analysis of agglomeration effect of biopharmaceutical industry in china and suggestions for its development. Chinese Medicinal Biotechnology, 2018,13(6):564-565.
[10]   濮润, 李萍萍, 苏月 , 等. 我国生物医药园区发展特点及未来发展建议. 中国生物工程杂志, 2015,35(3):104-106.
[10]   Pu R, Li P P, Su Y , et al. Development statuses and future suggestions of biomedical parks in China. China Biotechnology, 2015,35(3):104-106.
[1] . Retrovirus and Transgenic Chicken[J]. China Biotechnology, 2007, 27(7): 117-121.